Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. - Wikidata - wikimedia - TriplyDB

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

http://www.wikidata.org/entity/Q37571920

about

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data Erythropoietin Pathway: A Potential Target for the Treatment of Depression Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection Hypoxia: The Force that Drives Chronic Kidney Disease The pleiotropic effects of erythropoietin in infection and inflammation Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events Erythropoietin and Neonatal Neuroprotection Molecular mechanisms of ischemic preconditioning in the kidney Bridging Translation by Improving Preclinical Study Design in AKI The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection A new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survival ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney.A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathy.Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.No evidence for protective erythropoietin alpha signalling in rat hepatocytes.Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles Erythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.Cytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K.Serum erythropoietin levels in patients with central serous chorioretinopathy.Improved cerebrovascular function and reduced histological damage with darbepoietin alfa administration after cortical impact injury in rats A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis Erythropoietin action in stress response, tissue maintenance and metabolism.The Roles of Mechanical Stresses in the Pathogenesis of Osteoarthritis: Implications for Treatment of Joint Injuries.Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages.Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.Transcriptional ontogeny of the developing liver.Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma!Erythropoietin ameliorates early ischemia-reperfusion injury following the Pringle maneuver.Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.The effect of erythropoietin on normal and neoplastic cells.

P2860

Q24240202-656ABC5F-916C-4154-A6A7-B0E5AF241611 Q24242864-74FD273C-C8A0-4F53-91B5-4B52C11337BD Q26750850-2B039214-D821-403A-BBB8-71C556F02B1C Q26767146-3ADEC98B-315F-4BD5-A838-6E489192A975 Q26768865-B84D5C8B-68BD-4C24-B7A1-8DCEFEDE118E Q26864149-43E0B928-C370-481F-987E-F3DF112A939E Q26866295-CB863830-83A8-4DED-AD39-DDDAC8323C18 Q27009422-E0F68B6A-DA82-4661-ACCD-1C6E73F1E8C0 Q28080772-ECF0936C-F993-4E76-ACBA-1F7F2DACD834 Q28084530-91F21693-B3EF-4D91-871D-BC7DD67E8EBA Q28565261-7AF394DD-BC10-4668-9B63-A5660816A7F7 Q28575057-336ACAD4-5EE0-45FE-B909-49F6DDCDE464 Q28658933-3396AB76-9690-4BDB-BEC7-C96BD3036B3B Q28750073-ECEBD8DC-2F81-4F39-AF9B-E07A3E7CB7FD Q30483012-93A0D198-E562-4DD6-94A1-A6F3F93AF98E Q30486662-10F2DDDD-FDDF-402E-890D-09E76AB40CEA Q30502819-B779DD80-B9E4-4FBF-A9B5-03093BBDC929 Q30539892-7306BC27-BCF0-4E93-89F5-CC0A1CC4DDD3 Q31126222-4EC3E4B9-AA79-4223-8A7B-65D1FB34069F Q33288270-EF06D39D-35AE-4F4B-B2CD-B5A9C590BFF6 Q33326648-F1272F7D-8445-4155-B49B-289D5C173B05 Q33433206-F58B3F15-FDAB-4F13-B95D-2E9E031ECA07 Q33466769-0A2BA997-6D72-4077-BC3B-92AC88768EFA Q33482074-63D767CC-A33E-4678-AAF2-A872D3AD0D19 Q33619529-120032F8-4B8C-4340-896A-9206CABE141D Q33702107-23869E19-0CB7-4D27-A080-3109A9993935 Q33804787-7C6E7FB3-90DB-42E0-8431-71F14A797419 Q33836284-D9FE2AF0-297C-4707-810A-999AEB137C46 Q33864364-E271604F-3A9B-40A2-8D27-F45DE3989662 Q33907747-40FE41F7-E5B2-4698-8173-4463DE82D252 Q33945565-AB2576E7-94C6-4086-A24A-5D22FFA426A7 Q34024987-02ED72AB-87DB-4F93-9372-FC8C80135BB3 Q34063671-1DDB20C3-5FF5-46B6-BA24-8E8A06F72843 Q34069738-692662C6-BD3D-4045-AE4E-F5DEF6DC1D49 Q34132516-55BE3CBC-23E9-4BA0-B01A-FC36CA393A7D Q34133406-7CE17BB2-E49D-4C31-A198-52CCEA77BFB7 Q34164787-CA4FCDE4-0488-41A5-ADE2-AE432827817A Q34200868-FBF8E1C1-2A14-4760-97F7-A4286902A011 Q34219629-52ECB19E-A9D7-40FD-B882-F82CBE8B1717 Q34291437-38BB3BE7-506E-4A42-92E1-656937F5F3E6

P2860

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

http://www.wikidata.org/entity/Q37571920

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 September 2004

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@en

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@nl

type

label

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@en

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@nl

prefLabel

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@en

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@nl

P1433

Q37571920-4C505198-2DDC-431D-AF84-29DE8451650E

P1476

Q37571920-2314D6FA-58A6-40F2-8B74-E1E2952C5CD9

P2093

Q37571920-12769BDA-B27B-413B-B4ED-E3590A4934B0

Q37571920-13E46B66-7DF0-4BF5-9084-927AFA018256

Q37571920-16B76708-1A38-43DE-9C7D-C0423609CF5D

Q37571920-27C526F7-C5F1-4BD5-A498-551ED7AFEFB1

Q37571920-37943462-0D5B-40F0-8E89-3C62B4A06DB7

Q37571920-4E87E76C-C01A-4939-9FA1-664A5CC32147

Q37571920-61F0F690-0F23-4F4F-A03B-1A8ABCA932C5

Q37571920-7755B1A7-68A3-4435-A38D-7855AAA4C755

Q37571920-9285CAD4-F0CA-4425-B332-51B96257AEA2

Q37571920-B5034B2E-E5A3-4CA1-A85E-8E64EDACE4D1

P2860

Q37571920-02C09113-F752-43B1-83B2-1439C5B1AA87

Q37571920-04138FE1-4DCC-4F8F-9DC4-A4EE7F66322F

Q37571920-12D2663F-2C38-46B0-90F1-5904EA7FA4B9

Q37571920-18458722-4482-4B22-870F-2BEFCF9D8C20

Q37571920-2D309810-629C-4C29-8761-FBF1E55E0087

Q37571920-3D489313-3188-4231-BD70-5AF406C22D97

Q37571920-43ABA01F-DDB5-4640-A8F9-05D9A13D8619

Q37571920-47868C59-1AF9-47BD-8FA5-11E7EB464A3C

Q37571920-49AC46D6-D311-4E10-98D1-9E85628AFDB9

Q37571920-4DF67AE1-7D9D-4ED5-B50E-25D9756B0231

P304

Q37571920-0182767C-A8D5-4ABD-9778-A96ECE35FF4B

P31

Q37571920-A46C7541-6BD9-4F45-BE5E-E07020A316C3

P356

Q37571920-A6EDAA49-F8F8-44BF-BC63-26C3BD83E394

P407

Q37571920-25F94951-6B33-4CD2-9464-DF826769DE16

P433

Q37571920-83704D2F-1410-4115-8FCB-22F6224BA829

P478

Q37571920-CD81F173-2653-438A-888D-3EBAB7E9CD17

P577

Q37571920-3038411C-2C41-4408-A2A8-C79EEB7E9EEF

P5875

Q37571920-FC0C90BC-4D8D-43E3-9504-58A626CF62B2

P698

Q37571920-E399FF47-4FA3-4CC8-9ABB-ED61237BA2FE

P921

Q37571920-5B042076-9CE4-495F-AF61-2CBB428DC241

P932

Q37571920-2FAC6F4A-0D3E-40CB-A1C7-CDEC2CB2CE0B

P356

PNAS.0406491101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Erythropoietin mediates tissue ...... n beta-subunit heteroreceptor.

@en

P2093

Alessandra Sfacteria

http://www.w3.org/2001/XMLSchema#string

Anthony Cerami

http://www.w3.org/2001/XMLSchema#string

Carla Hand

http://www.w3.org/2001/XMLSchema#string

Chiao-Ju Su-Rick

http://www.w3.org/2001/XMLSchema#string

Daniel Gomez

http://www.w3.org/2001/XMLSchema#string

Deborah Diaz

http://www.w3.org/2001/XMLSchema#string

Eileen Pobre

http://www.w3.org/2001/XMLSchema#string

Fabio Fiordaliso

http://www.w3.org/2001/XMLSchema#string

Giovanni Grasso

http://www.w3.org/2001/XMLSchema#string

John Smart

http://www.w3.org/2001/XMLSchema#string

P2860

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

Structure of the activation domain of the GM-CSF/IL-3/IL-5 receptor common beta-chain bound to an antagonist

Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells

A sensitive and reliable locomotor rating scale for open field testing in rats

A model for assembly and activation of the GM-CSF, IL-3 and IL-5 receptors: insights from activated mutants of the common beta subunit.

Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.

Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex.

Interleukin-3 and interleukin-3 receptors in the brain.

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.

P304

14907-14912

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0406491101

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8258442

http://www.w3.org/2001/XMLSchema#string

P698

15456912

http://www.w3.org/2001/XMLSchema#string

P921

P932

522054

http://www.w3.org/2001/XMLSchema#string